These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33220063)

  • 1. Physiologically-Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
    Rowland Yeo K; Venkatakrishnan K
    Clin Pharmacol Ther; 2021 Jan; 109(1):51-54. PubMed ID: 33220063
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision Dosing: An Industry Perspective.
    Peck RW
    Clin Pharmacol Ther; 2021 Jan; 109(1):47-50. PubMed ID: 33107023
    [No Abstract]   [Full Text] [Related]  

  • 3. A unified pharmacokinetic approach to individualized drug dosing.
    Begg EJ; Chin PK
    Br J Clin Pharmacol; 2012 Mar; 73(3):335-9. PubMed ID: 21851378
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.
    Polasek TM; Rayner CR; Peck RW; Rowland A; Kimko H; Rostami-Hodjegan A
    Clin Pharmacol Drug Dev; 2019 May; 8(4):418-425. PubMed ID: 30500115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supporting Precision Dosing in Drug Labeling.
    Neely M; Onufrak N; Scheetz MH; Avedissian S; Lakota E; Deitchman AN; Gonzalez D
    Clin Pharmacol Ther; 2021 Jan; 109(1):37-41. PubMed ID: 33111328
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.
    Galetin A; Zhao P; Huang SM
    J Pharm Sci; 2017 Sep; 106(9):2204-2208. PubMed ID: 28390843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Critique of Pharmacokinetic Calculators for Drug Dosing Individualization.
    Janković SM
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):157-162. PubMed ID: 31773426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision dosing in clinical medicine: present and future.
    Polasek TM; Shakib S; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):743-746. PubMed ID: 30010447
    [No Abstract]   [Full Text] [Related]  

  • 9. Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians.
    Meesters K; Balbas-Martinez V; Allegaert K; Downes KJ; Michelet R
    Paediatr Drugs; 2024 Jul; 26(4):365-379. PubMed ID: 38755515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided Titration.
    Wang L; Maxfield K; Guinn D; Madabushi R; Zineh I; Schuck RN
    Clin Pharmacol Ther; 2021 Jan; 109(1):123-130. PubMed ID: 33022770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A best practice framework for applying physiologically-based pharmacokinetic modeling to pediatric drug development.
    Johnson TN; Small BG; Berglund EG; Rowland Yeo K
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):967-972. PubMed ID: 34288581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualizing the use of medications in children: making Goldilocks happy.
    Leeder JS; Brown JT; Soden SE
    Clin Pharmacol Ther; 2014 Sep; 96(3):304-6. PubMed ID: 24926777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Drug Dosage - Closing the Loop.
    Tucker GT
    Pharm Res; 2017 Aug; 34(8):1539-1543. PubMed ID: 27943015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
    Hoshitsuki K; Fernandez CA; Yang JJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Dosing: The Clinical Pharmacology of Goldilocks.
    Peck RW; Shahin MH; Vinks AA
    Clin Pharmacol Ther; 2021 Jan; 109(1):11-14. PubMed ID: 33616906
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real-World Setting.
    Maxfield K; Milligan L; Wang L; Gonzalez D; Johnson-Williams B; Liu Q; Madabushi R; Powell R; Wang Y; Zhu H; Zineh I
    Clin Pharmacol Ther; 2021 Jan; 109(1):25-28. PubMed ID: 32663324
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics.
    Howard M; Barber J; Alizai N; Rostami-Hodjegan A
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1315-1330. PubMed ID: 30465453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations.
    Kluwe F; Michelet R; Mueller-Schoell A; Maier C; Klopp-Schulze L; van Dyk M; Mikus G; Huisinga W; Kloft C
    Clin Pharmacol Ther; 2021 Jan; 109(1):29-36. PubMed ID: 33068303
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding and applying pharmacometric modelling and simulation in clinical practice and research.
    Standing JF
    Br J Clin Pharmacol; 2017 Feb; 83(2):247-254. PubMed ID: 27567102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for Drug Dosing in Premature Infants.
    van den Anker J; Allegaert K
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S141-S151. PubMed ID: 34185893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.